PMC:7029759 / 38735-39156
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1010 | 12-16 | Gene | denotes | ACE2 | Gene:59272 |
| 1011 | 288-297 | Species | denotes | 2019-nCoV | Tax:2697049 |
| 1012 | 16-19 | Chemical | denotes | -Fc | |
| 1013 | 120-139 | Disease | denotes | 2019-nCoV infection | MESH:C000657245 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T624 | 12-16 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T623 | 61-69 | GO:0042571 | denotes | antibody |
| T622 | 120-129 | SP_7 | denotes | 2019-nCoV |
| T621 | 288-297 | SP_7 | denotes | 2019-nCoV |
| T620 | 412-420 | CHEBI:36357;CHEBI:36357 | denotes | molecule |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T237 | 61-69 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T130 | 120-139 | Disease | denotes | 2019-nCoV infection | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T131 | 130-139 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T405 | 17-19 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T406 | 20-23 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T407 | 302-304 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T167 | 412-420 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T239 | 0-272 | Sentence | denotes | In summary, ACE2-Fc has the potential to be the neutralizing antibody that healthcare workers need to treat and prevent 2019-nCoV infection today and could play an important role in the cessation of the outbreak if manufacturing based on an available sequence starts soon. |
| T240 | 273-421 | Sentence | denotes | An alternative 2019-nCoV RBD-Fc fusion could also be pursued, if one desired the dual function of receptor blocking and vaccination in one molecule. |